In 2022, Wang’s team used YTHDF1 knockdown mice and primary CRC organoids to demonstrate that YTHDF1 can upregulate rho guanine nucleotide exchange factor 2 (ARHGEF2) gene expression and promote CRC metastasis and genesis (38). Here, ARHGEF2 is linked to colorectal carcinoma.